MarketReportsOnline.com adds "Global Hemophilia Market Report: 2015 Edition" report to its research store.
Hemophilia
is an inherited or acquired bleeding disorder that prevents blood from
clotting. People with hemophilia lack, either partially or completely, an
essential clotting factor needed to form stable blood clots. People with
hemophilia do not bleed any faster than normal, but they can bleed for a longer
time. Hemophilia is quite rare and about 1 in 10,000 people are born with it,
around 0.42 million people live with hemophilia. Hemophilia patients need to
replace the missing factor through infusions. The main treatment is called
replacement therapy, in which concentrates of clotting factor VIII (for
hemophilia A) or clotting factor IX (for hemophilia B) are injected into a
vein. More people suffer with hemophilia A in comparison to hemophilia B and
Inhibitors. The US accounts for the major population suffering with hemophilia
globally.
Complete report available at http://www.marketreportsonline.com/409838.html.
The key
trends observed in the market include introduction of new products increased
competition in rFVIII market and adoption of prophylactic treatment. On the
development front, there has been an increase in the launch of new products
like next-Generation long-acting Factor VIII and ready-to-use product by Novo
Nordisk. But there are certain challenges too which include high risk and cost
associated with new drugs, rising cost of hemophilia treatment and low
switching rate among patients. The future drivers of the industry are increased
rate of diagnosis and treatment, rising male population and global healthcare
expense among others.
The report
provides a comprehensive study of hemophilia market globally and also provides
detailed information for key regional markets. The competition in the global
hemophilia market is intense among large players like Baxter International
Inc., Novo Nordisk and Pfizer. All these companies have been profiled in the
present report highlighting their key financials and business strategies for
growth.
Purchase a copy of this research
report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=409838.
By combining
SPSS Inc.’s data integration and analysis capabilities with our relevant
findings, we have predicted the future growth of the industry. We employed
various significant variables that have an impact on this industry and created
regression models with SPSS Base to determine the future direction of the
industry. Before deploying the regression model, the relationship between
several independent or predictor variables and the dependent variable was
analyzed using standard SPSS output, including charts, tables and tests.
Table of Contents:
1. Overview
2. Market Analysis
2.2 Hemophilia Market by
Segments
2.3 Regional Analysis
3. Market Dynamics
3.1 Growth Drivers
3.2 Key Trends
3.3 Challenges
3.4 Significant
Developments
4. Competitive Landscape
4.1 Global
4.2 The US
5. Company Profiles
5.1 Baxter International
Inc.
5.2 Novo Nordisk
5.3 Pfizer, Inc.
6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
List of Tables
List of Charts
Other Related Reports on Pharmaceuticals Market:
About Us:
MarketReportsOnline
comprises of an online library of 2,50,000 reports and in-depth market research
studies of over 5000+ micro markets. We provide 24/7 online and offline support
to our customers. Get in touch with us for your needs of market research
reports.
Contact Us:
Ritesh Tiwari
Corporate Office
TX, Dallas North -
Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com 
No comments:
Post a Comment